Otsuka to produce and sell more fluids
Print Edition
OTSUKA Holdings Co, a major Japanese pharmaceutical company, intends to boost production and sales of high-end nutritional supplements in the Chinese market to meet rising demand.
China Otsuka Pharmaceutical Co, the company’s Chinese subsidiary, will build new assembly lines to boost the production of fluids packaged in soft bags, Japan’s Nikkei Newspaper reported. The expansion will help the company reach a capacity of 670 million units a year, three times the current level, the newspaper added.
Otsuka plans to increase output for the China market, and the company has invested at least 1 billion yuan (US$161 million) in its three plants in China and will “carry out further investment as required,” spokesman Hideki Shirai told Shanghai Daily yesterday.
Shirai added the company plans to raise the number of sales representatives to 500 from 300 now, and to hit 3.1 billion yuan in sales of transfusion fluids in China by 2019.
The transfusion fluids packaged in plastic bottles and soft bags, which are manufactured in the company’s factories in Tianjin, Dalian in Liaoning Province and Shunde in Guangdong Province, help patients get enough water and nutrients.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
